About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Irf1+
wild type
MGI:2180205
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
Irf1M1Btlr/Irf1+ C57BL/6J-Irf1M1Btlr MGI:4821110
ht2
Irf1tm1Mak/Irf1+ either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2) MGI:3769111
cx3
Faslpr/Faslpr
Irf1tm1Mak/Irf1+
MRL.Cg-Irf1tm1Mak Faslpr MGI:3769144


Genotype
MGI:4821110
ht1
Allelic
Composition
Irf1M1Btlr/Irf1+
Genetic
Background
C57BL/6J-Irf1M1Btlr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Irf1M1Btlr mutation (1 available); any Irf1 mutation (19 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• the blood of both homozygous and heterozygous mutant mice contains normal numbers of CD4+ T cells, CD19+ B cells and CD11c+ dendritic cells
• the bloood of heterozygous mutant mice contains a reduced number of NK1.1+ cells, intermediate between those of wild-type and of homozygous mutant mice
• the bloood of heterozygous mutant mice contains a reduced number of CD8+ cells, intermediate between those of wild-type and of homozygous mutant mice
• natural killer (NK) cells from previously immunized heterozygous mutant mice exhibit diminished ability to kill class I MHC-deficient cells in vivo; the level of killing is intermediate between that of wild-type and of homozygous mutant mice

immune system
N
• the blood of both homozygous and heterozygous mutant mice contains normal numbers of CD4+ T cells, CD19+ B cells and CD11c+ dendritic cells
• CD8+ cytotoxic T lymphocytes (CTL) from previously immunized homozygus and heterozygous mutant mice exhibit normal ability of to kill antigen-specific target cells in vivo
• the bloood of heterozygous mutant mice contains a reduced number of NK1.1+ cells, intermediate between those of wild-type and of homozygous mutant mice
• the bloood of heterozygous mutant mice contains a reduced number of CD8+ cells, intermediate between those of wild-type and of homozygous mutant mice
• natural killer (NK) cells from previously immunized heterozygous mutant mice exhibit diminished ability to kill class I MHC-deficient cells in vivo; the level of killing is intermediate between that of wild-type and of homozygous mutant mice
• heterozygous mutants exhibit enhanced susceptibility to infection with 2 x 105 PFU of mouse cytomegalovirus (MCMV)




Genotype
MGI:3769111
ht2
Allelic
Composition
Irf1tm1Mak/Irf1+
Genetic
Background
either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Irf1tm1Mak mutation (1 available); any Irf1 mutation (19 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice are viable and fertile, with no detectable abnormalities




Genotype
MGI:3769144
cx3
Allelic
Composition
Faslpr/Faslpr
Irf1tm1Mak/Irf1+
Genetic
Background
MRL.Cg-Irf1tm1Mak Faslpr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (83 available)
Irf1tm1Mak mutation (1 available); any Irf1 mutation (19 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 50% of mice die by 52 weeks; survival is increased relative to MRL-Faslpr mice

renal/urinary system
• not significantly different from Faslpr, Irf1-null mice or Faslpr, Irf1-sufficient mice
• at 26 weeks of age, mice show much less severe renal disease including IgG and C3 glomerular deposition compared to Faslpr homozygotes

hematopoietic system
• mice display similar T cell population profiles to Faslpr, Irf1-null mice

immune system
N
• TNF alpha production is not significantly different Faslpr, Irf1-sufficient mice or Faslpr, Irf1-null mice
• mice display similar T cell population profiles to Faslpr, Irf1-null mice
• at 26 weeks of age, levels are significantly higher relative to Faslpr, Irf1-null mice
• at 26 weeks of age, mice show much less severe renal disease including IgG and C3 glomerular deposition compared to Faslpr homozygotes

homeostasis/metabolism
• not significantly different from Faslpr, Irf1-null mice or Faslpr, Irf1-sufficient mice

integument
• mice display varying severity of skin irritation ranging from little or none to mild or moderate to severe





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/06/2026
MGI 6.24
The Jackson Laboratory